These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1329642)

  • 21. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila.
    Edelstein PH; Hu B; Edelstein MA
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2533-5. PubMed ID: 15917565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.
    Gómez-Lus R; Adrián F; del Campo R; Gómez-Lus P; Sánchez S; García C; Rubio MC
    Int J Antimicrob Agents; 2001 Jul; 18(1):49-54. PubMed ID: 11463526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
    Higa F; Akamine M; Haranaga S; Tohyama M; Shinzato T; Tateyama M; Koide M; Saito A; Fujita J
    J Antimicrob Chemother; 2005 Dec; 56(6):1053-7. PubMed ID: 16260445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activities of gemifloxacin versus five quinolones and two macrolides against 271 Spanish isolates of Legionella pneumophila: influence of charcoal on susceptibility test results.
    García MT; Pelaz C; Giménez MJ; Aguilar L
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2176-8. PubMed ID: 10898695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic susceptibility of environmental
    Sreenath K; Chaudhry R; Vinayaraj EV; Thakur B
    Future Microbiol; 2019 May; 14():661-669. PubMed ID: 31148475
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the bactericidal activity of temafloxacin.
    Jacobs MR
    Am J Med; 1991 Dec; 91(6A):31S-34S. PubMed ID: 1662893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic susceptibility of Legionella pneumophila strains isolated in England and Wales 2007-17.
    Wilson RE; Hill RLR; Chalker VJ; Mentasti M; Ready D
    J Antimicrob Chemother; 2018 Oct; 73(10):2757-2761. PubMed ID: 30053025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.
    Baltch AL; Bopp LH; Smith RP; Michelsen PB; Ritz WJ
    J Antimicrob Chemother; 2005 Jul; 56(1):104-9. PubMed ID: 15941776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-streptococcal activity of SB-265805 (LB20304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelines.
    Johnson DM; Jones RN; Erwin ME
    Diagn Microbiol Infect Dis; 1999 Feb; 33(2):87-91. PubMed ID: 10091031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
    Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A
    J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial agent susceptibilities of Legionella pneumophila MLVA-8 genotypes.
    Sharaby Y; Nitzan O; Brettar I; Höfle MG; Peretz A; Halpern M
    Sci Rep; 2019 Apr; 9(1):6138. PubMed ID: 30992549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimum inhibitory concentration (MIC) distribution among wild-type strains of Legionella pneumophila identifies a subpopulation with reduced susceptibility to macrolides owing to efflux pump genes.
    Vandewalle-Capo M; Massip C; Descours G; Charavit J; Chastang J; Billy PA; Boisset S; Lina G; Gilbert C; Maurin M; Jarraud S; Ginevra C
    Int J Antimicrob Agents; 2017 Nov; 50(5):684-689. PubMed ID: 28782709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
    Baltch AL; Smith RP; Ritz W
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.
    Edelstein PH; Edelstein MA
    Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens.
    Guinea J; Gargallo-Viola D; Robert M; Tudela E; Xicota MA; Garcia J; Esteve M; Coll R; Pares M; Roser R
    Antimicrob Agents Chemother; 1995 Feb; 39(2):413-21. PubMed ID: 7726507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibilities of Legionella spp. to newer antimicrobials in vitro.
    Schülin T; Wennersten CB; Ferraro MJ; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1520-3. PubMed ID: 9624509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of antimicrobial agents against Legionella isolated from environmental water systems: first results from Turkey.
    Erdogan H; Can F; Demirbilek M; Timurkaynak F; Arslan H
    Environ Monit Assess; 2010 Dec; 171(1-4):487-91. PubMed ID: 20049525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of BAY 12-8039, a new fluoroquinolone.
    Woodcock JM; Andrews JM; Boswell FJ; Brenwald NP; Wise R
    Antimicrob Agents Chemother; 1997 Jan; 41(1):101-6. PubMed ID: 8980763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Lehr KH; Ren J
    J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.